EPISODE · Apr 22, 2026 · 7 MIN
2377: hVIVO Lands Landmark Phase III Trial
from The Vox Markets Podcast · host Vox Markets Podcast
hVIVO has been selected to run the world’s first pivotal Phase III human challenge trial in whooping cough, marking a major scientific milestone and its largest study to date. The contract strengthens revenue visibility into 2026–27 while underlining the growing importance of human challenge trials in accelerating vaccine approvals globally.
NOW PLAYING
2377: hVIVO Lands Landmark Phase III Trial
0:00
7:19
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Vox Markets Podcast?
This episode is 7 minutes long.
When was this The Vox Markets Podcast episode published?
This episode was published on April 22, 2026.
What is this episode about?
hVIVO has been selected to run the world’s first pivotal Phase III human challenge trial in whooping cough, marking a major scientific milestone and its largest study to date. The contract strengthens revenue visibility into 2026–27 while...
Can I download this The Vox Markets Podcast episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!